Literature DB >> 12885348

Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.

Xianzheng Zhou1, Yan Cui, Xin Huang, Zhiwei Yu, Amy M Thomas, Zhaohui Ye, Drew M Pardoll, Elizabeth M Jaffee, Linzhao Cheng.   

Abstract

In this report, we evaluated the efficiency of stable gene transfer into established CD8(+) human tumor antigen-specific cytotoxic T cell (CTL) lines and peripheral blood lymphocytes (PBL) by oncoretroviral and lentiviral vectors. In the oncoretroviral vector, the green fluorescent protein (GFP) reporter gene was regulated by the murine stem cell virus (MSCV) promoter. In three human immunodeficiency virus type 1 (HIV-1)-based lentiviral vectors, the GFP transgene was regulated by either a chimeric MSCV/HIV-1 promoter, or cellular promoters from human housekeeping genes PGK and EF1 alpha. We found that several lines of proliferating tumor-specific CTL were poorly (=2%) transduced by the oncoretroviral vector that transduced Jurkat T cell line efficiently (=80%). In contrast, three lentiviral vectors transduced 38-63% of these proliferating CTL. More interestingly, all lentiviral vectors packaged without the HIV-1 accessory proteins transduced human bulk PBL and purified CD4(+) and CD8(+) lymphocyte subsets without prior stimulation. Detailed analysis indicated that the lentiviral vectors containing the EF1 alpha or PGK ubiquitous promoter can transduce unstimulated PBL and achieve low-level transgene expression in the absence of any T-cell activation. However, T-cell activation subsequent to the transduction of unstimulated PBL is required for high-level transgene expression. Transduced PBL expressing transgene delivered by the lentiviral vectors still preserved resting and naïve cell phenotypes. Taken together, prior T cell stimulation and HIV-1 accessory proteins are dispensable for lentivirus-mediated gene transfer into resting naïve and memory T lymphocytes. These results will have significant implications for the study of T-cell biology and for the improvement of clinical gene therapies of acquired immune deficiency syndrome (AIDS) and cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885348     DOI: 10.1089/104303403322124800

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  19 in total

1.  Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studies.

Authors:  Sid P Kerkar; Luis Sanchez-Perez; Shicheng Yang; Zachary A Borman; Pawel Muranski; Yun Ji; Dhanalakshmi Chinnasamy; Andrew D M Kaiser; Christian S Hinrichs; Christopher A Klebanoff; Christopher D Scott; Luca Gattinoni; Richard A Morgan; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunother       Date:  2011-05       Impact factor: 4.456

2.  Hedgehog signaling stimulates Tenascin C to promote invasion of pancreatic ductal adenocarcinoma cells through Annexin A2.

Authors:  Kelly Foley; Stephen Muth; Elizabeth Jaffee; Lei Zheng
Journal:  Cell Adh Migr       Date:  2017-02-06       Impact factor: 3.405

3.  Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.

Authors:  Xin Huang; Andrew C Wilber; Lei Bao; Dong Tuong; Jakub Tolar; Paul J Orchard; Bruce L Levine; Carl H June; R Scott McIvor; Bruce R Blazar; Xianzheng Zhou
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

Review 4.  Rebalancing immune specificity and function in cancer by T-cell receptor gene therapy.

Authors:  Akshata Udyavar; Terrence L Geiger
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-08-01       Impact factor: 4.291

5.  Adoptive immunotherapy of cancer: Gene transfer of T cell specificity.

Authors:  Amir A Al-Khami; Shikhar Mehrotra; Michael I Nishimura
Journal:  Self Nonself       Date:  2011-04-01

6.  In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).

Authors:  Malarvizhi Durai; Christine Krueger; Zhaohui Ye; Linzhao Cheng; Andreas Mackensen; Mathias Oelke; Jonathan P Schneck
Journal:  Cancer Immunol Immunother       Date:  2008-06-18       Impact factor: 6.968

7.  Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity.

Authors:  P D Peng; C J Cohen; S Yang; C Hsu; S Jones; Y Zhao; Z Zheng; S A Rosenberg; R A Morgan
Journal:  Gene Ther       Date:  2009-06-04       Impact factor: 5.250

8.  Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes.

Authors:  Stephanie Jones; Peter D Peng; Shicheng Yang; Cary Hsu; Cyrille J Cohen; Yangbing Zhao; John Abad; Zhili Zheng; Steven A Rosenberg; Richard A Morgan
Journal:  Hum Gene Ther       Date:  2009-06       Impact factor: 5.695

9.  Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.

Authors:  Carmine Carpenito; Michael C Milone; Raffit Hassan; Jacqueline C Simonet; Mehdi Lakhal; Megan M Suhoski; Angel Varela-Rohena; Kathleen M Haines; Daniel F Heitjan; Steven M Albelda; Richard G Carroll; James L Riley; Ira Pastan; Carl H June
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

10.  Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.

Authors:  Kelly Foley; Agnieszka A Rucki; Qian Xiao; Donger Zhou; Ashley Leubner; Guanglan Mo; Jennifer Kleponis; Annie A Wu; Rajni Sharma; Qingguang Jiang; Robert A Anders; Christine A Iacobuzio-Donahue; Katherine A Hajjar; Anirban Maitra; Elizabeth M Jaffee; Lei Zheng
Journal:  Sci Signal       Date:  2015-08-04       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.